Skip to main content
. 2022 Jan 14;22:27. doi: 10.1186/s12883-021-02545-6

Fig. 3.

Fig. 3

Comparison of mRS scores before treatment, after treatment and improved between non-SE and SE anti-NMDAR encephalitis patients. p < 0.05 was considered as significant. A mRS scores before treatment; B mRS scores after treatment; C mRS scores improved. The improved mRS scores was the change of mRS scores after treatment compared with before treatment. Non-SE, non-status epilepticus; SE, status epilepticus; anti-NMDAR, anti-N-methyl-D-aspartate receptor; mRS, modified Rankin scale